Insider Selling: Fennec Pharmaceuticals Inc (NASDAQ:FENC) COO Sells 22,222 Shares of Stock

Fennec Pharmaceuticals Inc (NASDAQ:FENC – Get Free Report) COO Adrian Haigh sold 22,222 shares of the company’s stock in a transaction dated Friday, April 19th. The shares were sold at an average price of $9.34, for a total transaction of $207,553.48. The transaction was disclosed in a legal filing with the SEC, which can be […]

Related Keywords

United States ,Craig Hallum ,Adrian Haigh ,Fennec Pharmaceuticals Inc ,Hedge Funds Weigh In On Fennec Pharmaceuticals ,Hartford Financial Management Inc ,News Ratings For Fennec Pharmaceuticals Daily ,Fennec Pharmaceuticals Trading ,Fennec Pharmaceuticals ,Fennec Pharmaceuticals Company Profile ,Eudaimonia Advisors ,Tower Research Capital ,Quarter For Fennec Pharmaceuticals ,Allspring Global Investments Holdings ,Jump Financial ,Get Free Report ,Pharmaceuticals Inc ,Research Capital ,Global Investments Holdings ,Hartford Financial Management ,Financial Management ,Sodium Thiosulfate ,Fennec Pharmaceuticals Daily ,Nasdaq Fenc ,Pufenc ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,